![(7S)-N-[[5-(Ethylsulfonyl)-2-pyridinyl]methyl]-6,7-dihydro-7-(1-methylethyl)-6-[[trans-4-(trifluor…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FCXC70604.webp&w=3840&q=75)

(7S)-N-[[5-(Ethylsulfonyl)-2-pyridinyl]methyl]-6,7-dihydro-7-(1-methylethyl)-6-[[trans-4-(trifluoromethyl)cyclohexyl]methyl]-5H-Pyrr olo[3,4-b]pyridine-3-carboxamide
CAS:
Ref. 3D-CXC70604
![(7S)-N-[[5-(Ethylsulfonyl)-2-pyridinyl]methyl]-6,7-dihydro-7-(1-methylethyl)-6-[[trans-4-(trifluor…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FCXC70604.webp&w=3840&q=75)

Product Information
Name:(7S)-N-[[5-(Ethylsulfonyl)-2-pyridinyl]methyl]-6,7-dihydro-7-(1-methylethyl)-6-[[trans-4-(trifluoromethyl)cyclohexyl]methyl]-5H-Pyrr olo[3,4-b]pyridine-3-carboxamide
Brand:Biosynth
Description:(7S)-N-[[5-(Ethylsulfonyl)-2-pyridinyl]methyl]-6,7-dihydro-7-(1-methylethyl)-6-[[trans-4-(trifluoromethyl)cyclohexyl]methyl]-5H-Pyrr olo[3,4-b]pyridine-3-carboxamide is a drug candidate for the treatment of lymphocytic leukemia and other cancers. It has shown inhibitory effects on cardiac cells that are not present in primary cells or cancer cells. This drug also has been shown to have an antiangiogenic effect on pancreatic cancer and chronic lymphocytic leukemia. (7S)-N-[5-(ethylsulfonyl)-2-pyridinyl]methyl]-6, 7-dihydro-7-(1 -methylethyl)-6-[(trans, trans 4
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:552.65 g/mol
Formula:C27H35F3N4O3S
Purity:Min. 95%